Fibroids are benign tumours composed of smooth muscle and fibrous tissue that develop in the uterus. The most common types are intramural, subserous, and submucous fibroids. Fibroids often cause heavy menstrual bleeding and can lead to infertility or pregnancy complications. Diagnosis is usually made through pelvic exam and ultrasound. While many small fibroids require no treatment, larger or symptomatic fibroids may warrant surgery.
This document discusses abnormal uterine bleeding (AUB), which is defined as any abnormalities in menstrual cycle length, flow duration, or amount. It provides details on the types of AUB, causes by age group, evaluation, differential diagnosis, and management. The main types of AUB include amenorrhea, dysmenorrhea, menorrhagia, oligomenorrhea, and metrorrhagia. Causes can be organic lesions, anovulatory cycles, coagulation disorders, or dysfunctional uterine bleeding. Evaluation involves history, exam, lab tests like CBC and imaging. Management options include general measures, medical treatment with hormones or intrauterine devices, and surgical intervention if needed.
This document discusses common causes and approaches to evaluating and managing postmenopausal vaginal bleeding. Key causes mentioned include atrophic vaginitis, endometrial hyperplasia, uterine polyps, endometrial cancer, and exogenous estrogen use. The diagnostic approach involves a detailed history, examination, transvaginal ultrasound, hysteroscopy, and biopsy. Initial stabilization priorities bleeding control. Long-term management depends on the underlying cause and may involve hormone therapy, surgery, or chemotherapy/radiotherapy. Counseling supports informed decision making and long-term follow up.
The document discusses the new FIGO classification system for abnormal uterine bleeding (AUB). It introduces the PALM-COEIN system which provides a standardized terminology and classification. The system categorizes AUB into structural causes (polyps, adenomyosis, leiomyoma, malignancy) and non-structural causes (coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, not yet classified). It provides guidelines for evaluation and outlines the notation system for documenting multiple contributing factors to a patient's AUB. The standardized classification aims to improve management of AUB internationally through a unified terminology and focus on appropriate treatment concepts.
This document discusses genitourinary fistulas, including their classification, causes, symptoms, investigations, management, and prevention. The main types of fistulas are vesicovaginal, urethrovaginal, and ureterovaginal. Obstetric causes like obstructed labor are common in developing countries, while surgical trauma is more common in developed countries. Symptoms include continuous urine leakage. Investigations include dye tests and imaging. Management depends on the fistula type and complexity, and may involve surgical repair techniques like saucerization. Prevention focuses on adequate obstetric and surgical care to avoid injury.
Endometriosis and adenomyosis are common gynecological conditions where endometrial tissue grows outside or inside the uterus respectively. Endometriosis occurs when endometrial tissue implants itself in areas like the ovaries or pelvic wall, causing pain and infertility. Adenomyosis involves the growth of endometrial tissue deep in the uterine wall. Both are estrogen-dependent and resolve after menopause. Treatment options include medication to induce amenorrhea and reduce symptoms, or surgery for severe cases or women who have completed childbearing. Hysterectomy provides the only cure for adenomyosis.
This document discusses abnormal uterine bleeding (AUB), providing definitions, terminology, and etiologies. It describes the normal menstrual cycle and defines AUB as bleeding that is abnormal in duration, volume, frequency, or regularity. Common etiologies of AUB are organized using the PALM-COEIN system, including structural issues like polyps, adenomyosis, and leiomyomas. Diagnosis involves taking a history, examining the patient, and running targeted tests. Treatment for acute AUB focuses on stabilization, while chronic AUB may be treated with medical options, procedures, or surgery depending on the individual.
This document provides information on the evaluation and management of abnormal uterine bleeding (AUB). It begins with definitions of terms and classifications of AUB. Evaluation involves a history, physical exam, and testing as needed which may include ultrasound, hysteroscopy, or endometrial biopsy to determine the cause. Causes are categorized using the FIGO PALM-COEIN system. Treatment options discussed include general measures, medical therapies like hormones, NSAIDs, tranexamic acid, and surgical procedures such as endometrial ablation or hysterectomy. Non-hormonal and hormonal medical treatments are summarized. The document concludes with a discussion of progestin therapies.
Uterine fibroids are non-cancerous tumors that originate from the uterus. They are very common in women of reproductive age, affecting 20-40% of women. Symptoms can include abnormal uterine bleeding, infertility, pain, and pressure. Diagnosis involves physical exam, ultrasound, MRI, and sometimes biopsy. Treatment options include medical management using hormones to shrink fibroids, surgical procedures such as myomectomy to remove fibroids or hysterectomy to remove the uterus, and uterine artery embolization. Nursing care focuses on pain management, monitoring for bleeding and infection, encouraging mobility and nutrition, and providing education and emotional support.
This document discusses abnormal uterine bleeding (AUB), which is defined as any abnormalities in menstrual cycle length, flow duration, or amount. It provides details on the types of AUB, causes by age group, evaluation, differential diagnosis, and management. The main types of AUB include amenorrhea, dysmenorrhea, menorrhagia, oligomenorrhea, and metrorrhagia. Causes can be organic lesions, anovulatory cycles, coagulation disorders, or dysfunctional uterine bleeding. Evaluation involves history, exam, lab tests like CBC and imaging. Management options include general measures, medical treatment with hormones or intrauterine devices, and surgical intervention if needed.
This document discusses common causes and approaches to evaluating and managing postmenopausal vaginal bleeding. Key causes mentioned include atrophic vaginitis, endometrial hyperplasia, uterine polyps, endometrial cancer, and exogenous estrogen use. The diagnostic approach involves a detailed history, examination, transvaginal ultrasound, hysteroscopy, and biopsy. Initial stabilization priorities bleeding control. Long-term management depends on the underlying cause and may involve hormone therapy, surgery, or chemotherapy/radiotherapy. Counseling supports informed decision making and long-term follow up.
The document discusses the new FIGO classification system for abnormal uterine bleeding (AUB). It introduces the PALM-COEIN system which provides a standardized terminology and classification. The system categorizes AUB into structural causes (polyps, adenomyosis, leiomyoma, malignancy) and non-structural causes (coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, not yet classified). It provides guidelines for evaluation and outlines the notation system for documenting multiple contributing factors to a patient's AUB. The standardized classification aims to improve management of AUB internationally through a unified terminology and focus on appropriate treatment concepts.
This document discusses genitourinary fistulas, including their classification, causes, symptoms, investigations, management, and prevention. The main types of fistulas are vesicovaginal, urethrovaginal, and ureterovaginal. Obstetric causes like obstructed labor are common in developing countries, while surgical trauma is more common in developed countries. Symptoms include continuous urine leakage. Investigations include dye tests and imaging. Management depends on the fistula type and complexity, and may involve surgical repair techniques like saucerization. Prevention focuses on adequate obstetric and surgical care to avoid injury.
Endometriosis and adenomyosis are common gynecological conditions where endometrial tissue grows outside or inside the uterus respectively. Endometriosis occurs when endometrial tissue implants itself in areas like the ovaries or pelvic wall, causing pain and infertility. Adenomyosis involves the growth of endometrial tissue deep in the uterine wall. Both are estrogen-dependent and resolve after menopause. Treatment options include medication to induce amenorrhea and reduce symptoms, or surgery for severe cases or women who have completed childbearing. Hysterectomy provides the only cure for adenomyosis.
This document discusses abnormal uterine bleeding (AUB), providing definitions, terminology, and etiologies. It describes the normal menstrual cycle and defines AUB as bleeding that is abnormal in duration, volume, frequency, or regularity. Common etiologies of AUB are organized using the PALM-COEIN system, including structural issues like polyps, adenomyosis, and leiomyomas. Diagnosis involves taking a history, examining the patient, and running targeted tests. Treatment for acute AUB focuses on stabilization, while chronic AUB may be treated with medical options, procedures, or surgery depending on the individual.
This document provides information on the evaluation and management of abnormal uterine bleeding (AUB). It begins with definitions of terms and classifications of AUB. Evaluation involves a history, physical exam, and testing as needed which may include ultrasound, hysteroscopy, or endometrial biopsy to determine the cause. Causes are categorized using the FIGO PALM-COEIN system. Treatment options discussed include general measures, medical therapies like hormones, NSAIDs, tranexamic acid, and surgical procedures such as endometrial ablation or hysterectomy. Non-hormonal and hormonal medical treatments are summarized. The document concludes with a discussion of progestin therapies.
Uterine fibroids are non-cancerous tumors that originate from the uterus. They are very common in women of reproductive age, affecting 20-40% of women. Symptoms can include abnormal uterine bleeding, infertility, pain, and pressure. Diagnosis involves physical exam, ultrasound, MRI, and sometimes biopsy. Treatment options include medical management using hormones to shrink fibroids, surgical procedures such as myomectomy to remove fibroids or hysterectomy to remove the uterus, and uterine artery embolization. Nursing care focuses on pain management, monitoring for bleeding and infection, encouraging mobility and nutrition, and providing education and emotional support.
This document discusses abnormal uterine bleeding and its causes and treatment. It begins with an overview of the normal menstrual cycle and mechanisms of menstruation. It then describes abnormal uterine bleeding, including definitions and types such as polymenorrhea, menorrhagia, and metrorrhagia. The document outlines approaches to diagnosis, including history, examination, lab tests, imaging and procedures. It discusses evaluation of endometrial pathology and various organic and dysfunctional causes of abnormal bleeding. Finally, it provides guidance on treatment, including non-hormonal and hormonal medical options as well as surgical interventions.
This document discusses postmenopausal bleeding, defined as any vaginal bleeding occurring more than 12 months after a woman's last menstrual period. The most common causes are atrophic vaginitis (60-80%), estrogen treatments (15-25%), and cervical or uterine polyps (2-12%). Evaluation involves obtaining a medical history, performing a clinical examination including a cervical smear and pelvic exam, and diagnostic testing such as ultrasound and endometrial biopsy. Treatment depends on the underlying cause, but may include hormone therapy for atrophic vaginitis or polyp removal, and in some cases of hyperplasia or cancer, hysterectomy.
This document discusses sepsis in obstetrics and gynecology. It defines sepsis and its spectrum, outlines diagnostic criteria and risk factors. Common causes are infections during labor, delivery or postpartum. The pathophysiology involves an exaggerated immune response leading to organ dysfunction. Investigations and management of sepsis are medical emergencies focusing on IV fluids, antibiotics, source control and vasopressors to support blood pressure. Prevention emphasizes antibiotic prophylaxis for at-risk groups like GBS carriers.
This document discusses chronic pelvic pain (CPP), which is defined as intermittent or constant pain in the lower abdomen or pelvis lasting at least 6 months. CPP has many potential causes including endometriosis, adhesions, pelvic congestion syndrome, irritable bowel syndrome, interstitial cystitis, and nerve entrapment syndromes. A thorough history, exam, and testing are needed to evaluate CPP and identify potential causes. Treatment is multidisciplinary and may include medications, physiotherapy, laparoscopy, and hysterectomy depending on the underlying etiology. Managing CPP requires a multidisciplinary approach and treatment of any associated psychological factors.
This document presents a case of a 44-year-old woman presenting with abnormal uterine bleeding for 23 days. Her workup showed severe anemia. She was diagnosed with AUB and treated with blood transfusions. Abnormal uterine bleeding is defined as bleeding outside normal volume, duration, or frequency. It can be caused by various structural, hematological, endocrine or other issues. Dysfunctional uterine bleeding is defined as abnormal bleeding without an organic cause, and can be ovulatory or anovulatory. Initial management of AUB involves determining the cause and treating any underlying issues medically or surgically.
Functional ovarian cyst and its differential diagnosis Cheng Ting
Functional ovarian cysts are non-cancerous cysts that form due to a temporary hormonal imbalance. They are usually unilateral, asymptomatic, and less than 8 cm in diameter. Functional cysts contain clear fluid and will typically resolve on their own once the hormonal imbalance is addressed. Differential diagnoses for ovarian cysts include ectopic pregnancy, ovarian tumors, and other gastrointestinal or genitourinary conditions. Distinguishing features between functional and cancerous cysts include cyst size, consistency, location, presence of ascites, and diagnostic imaging results.
Adenomyosis is a benign condition where endometrial tissue grows into the myometrium. It causes the uterus to enlarge asymmetrically, especially on the posterior wall. Women with adenomyosis typically experience heavy menstrual bleeding and painful periods that can occur throughout the month. Ultrasound and MRI can detect adenomyosis by showing cysts in the thickened myometrium and an indistinct endomyometrial junction. Treatment depends on a woman's age and fertility desires, ranging from medication like NSAIDs and oral contraceptives to hysterectomy for older, parous women.
Uterine prolapse was first documented in ancient Egypt. The first successful vaginal hysterectomy to treat uterine prolapse was self-performed in 1670. Pelvic organ prolapse has a lifetime risk of around 11% requiring surgery. The uterus is normally supported by the endopelvic fascia, ligaments, and pelvic floor muscles. Prolapse can involve the bladder, uterus, rectum, or vagina descending from their normal positions. Conservative treatment includes pessaries while surgical repair is also used to manage uterine prolapse.
This document discusses fibroids, which are benign growths in the uterus. It notes that fibroids are very common, affecting up to 40% of women, and are more common and symptomatic in black women. While the exact causes are unknown, fibroids develop from the muscle cells of the uterus. The symptoms depend on the location, number, and size of fibroids. Treatment options include medication to manage symptoms, uterine artery embolization to reduce fibroids, and surgical options like myomectomy and hysteroscopic myomectomy to remove fibroids.
Women with benign heavy menstrual bleeding have the choice of a number of medical treatment options to reduce their blood loss and improve quality of life.
This document discusses endometritis, including acute, chronic, and atrophic types. Acute endometritis usually occurs after abortion or childbirth and is caused by various bacteria. Chronic endometritis results from a persistent infection in the uterine cavity caused by things like IUDs or retained products. Atrophic endometritis occurs in postmenopausal women due to loss of estrogen protection. Clinical features include vaginal discharge and abdominal or pelvic pain. Diagnosis involves tests like cervical smears, ultrasounds, and endometrial biopsies. Treatment involves removing the infection source and using antibiotics.
Hematocolpos is a blood-filled dilated vagina caused by menstrual blood buildup due to an anatomical obstruction. It can occur due to conditions like an imperforate hymen or transverse vaginal septum, which is a rare congenital vertical fusion defect that can be either perforate or imperforate and occurs most often in the superior vagina. Patients may experience amenorrhea or abdominal pain, and physical examination can help identify the cause.
This document discusses induction of labor, including its definition, indications, contraindications, methods, and risks. It defines induction of labor as planned initiation of uterine contractions before spontaneous onset. Common indications include prolonged pregnancy and fetal growth restriction. Contraindications include placenta previa and severe fetal compromise. Methods discussed include membrane stripping, amniotomy, prostaglandins like misoprostol and dinoprostone, and oxytocin. Risks of induction include greater pain, uterine hyperstimulation, cord prolapse, and potential need for C-section if induction fails. The document provides three scenarios involving induction and asks for opinions on indications and complications.
Genital tuberculosis is a major health problem in developing countries. It spreads hematogenously from a primary pulmonary infection to the fallopian tubes. Clinical features include infertility, chronic pelvic pain, and menstrual abnormalities. Diagnosis involves blood tests, imaging, endometrial biopsy, and laparoscopy. Treatment consists of a multi-drug chemotherapy regimen for 9-12 months. Prognosis is good for cure but fertility is often not restored due to tubal damage. Surgery may be needed for complications like pyosalpinx but does not improve fertility.
A medical abortion, also known as medication abortion, is a type of non-surgical abortion in which medication is used to bring about abortion. This inflammation is shared with the client in our Clinic.
A Bartholin's cyst is a fluid-filled sac within the Bartholin's gland of the vagina. Bartholin's cysts typically occur in nulliparous women of child-bearing age and other risk factors include a personal history of Bartholin's cyst, being sexually active, or a history of vulval surgery. Bartholin's cysts can cause vulvar pain, dyspareunia, and may rupture spontaneously, relieving pain. Treatment options include incision and drainage with placement of a Word catheter or marsupialization to prevent reaccumulation of fluid.
Bacterial infections during childbirth can lead to sepsis, a life-threatening condition caused by the body's response to an infection. Sepsis is a global leading cause of maternal mortality, accounting for 1 in 10 maternal deaths worldwide. The diagnostic criteria for sepsis include symptoms like fever, increased heart rate, respiratory rate and blood markers of infection. Early goal-directed treatment within 3-6 hours including antibiotics, fluid resuscitation and source control can improve outcomes. Ongoing monitoring and organ support is often needed. Risk factors like obesity, diabetes and preterm rupture of membranes increase the risk of sepsis in pregnancy.
Dysfunctional uterine bleeding (DUB) is a common cause of abnormal uterine bleeding outside of pregnancy, and is caused by functional abnormalities of the hypothalamic-pituitary axis. DUB accounts for the large majority of abnormal uterine bleeding cases. Evaluation involves obtaining a detailed history, physical exam, and endometrial sampling. Treatment options include medical management with various hormonal regimens or surgical options like endometrial ablation or hysterectomy.
F.I.G.O. GUIDELINES & MEDICAL MANAGEMENT OF A.U.B. ( FOCUS ON PROGESTERONE ) ...DR SHASHWAT JANI
This document provides guidelines for evaluating and managing abnormal uterine bleeding (AUB). It discusses the FIGO classification system for AUB which categorizes causes as structural (polyps, adenomyosis, leiomyomas, malignancy) or non-structural (coagulopathy, ovulatory dysfunction, endometrial). Evaluation involves history, physical exam, labs including pregnancy test and CBC, and imaging like ultrasound and hysteroscopy. Treatment focuses on treating the underlying cause, with hormonal therapy commonly used for non-structural causes.
This document discusses fibroids in pregnancy. It notes that fibroids are benign muscle tumors that are quite common, affecting around 1 in 1000 pregnancies. While fibroids often cause no issues, they can sometimes lead to complications for the pregnancy like abortion, preterm labor, malpresentation, or obstructed labor. The effects of pregnancy on fibroids are also covered, as fibroids often enlarge during pregnancy due to increased blood flow and hormones. The diagnosis, management, and treatment of fibroids during pregnancy and delivery are discussed. In general, vaginal delivery is preferred when possible and surgery is avoided during pregnancy.
Seminar presentation by student under supervision of endocrinology specialist from HRPZ. References as mentioned in the slides. Mostly from Malaysia CPG.
This document discusses abnormal uterine bleeding and its causes and treatment. It begins with an overview of the normal menstrual cycle and mechanisms of menstruation. It then describes abnormal uterine bleeding, including definitions and types such as polymenorrhea, menorrhagia, and metrorrhagia. The document outlines approaches to diagnosis, including history, examination, lab tests, imaging and procedures. It discusses evaluation of endometrial pathology and various organic and dysfunctional causes of abnormal bleeding. Finally, it provides guidance on treatment, including non-hormonal and hormonal medical options as well as surgical interventions.
This document discusses postmenopausal bleeding, defined as any vaginal bleeding occurring more than 12 months after a woman's last menstrual period. The most common causes are atrophic vaginitis (60-80%), estrogen treatments (15-25%), and cervical or uterine polyps (2-12%). Evaluation involves obtaining a medical history, performing a clinical examination including a cervical smear and pelvic exam, and diagnostic testing such as ultrasound and endometrial biopsy. Treatment depends on the underlying cause, but may include hormone therapy for atrophic vaginitis or polyp removal, and in some cases of hyperplasia or cancer, hysterectomy.
This document discusses sepsis in obstetrics and gynecology. It defines sepsis and its spectrum, outlines diagnostic criteria and risk factors. Common causes are infections during labor, delivery or postpartum. The pathophysiology involves an exaggerated immune response leading to organ dysfunction. Investigations and management of sepsis are medical emergencies focusing on IV fluids, antibiotics, source control and vasopressors to support blood pressure. Prevention emphasizes antibiotic prophylaxis for at-risk groups like GBS carriers.
This document discusses chronic pelvic pain (CPP), which is defined as intermittent or constant pain in the lower abdomen or pelvis lasting at least 6 months. CPP has many potential causes including endometriosis, adhesions, pelvic congestion syndrome, irritable bowel syndrome, interstitial cystitis, and nerve entrapment syndromes. A thorough history, exam, and testing are needed to evaluate CPP and identify potential causes. Treatment is multidisciplinary and may include medications, physiotherapy, laparoscopy, and hysterectomy depending on the underlying etiology. Managing CPP requires a multidisciplinary approach and treatment of any associated psychological factors.
This document presents a case of a 44-year-old woman presenting with abnormal uterine bleeding for 23 days. Her workup showed severe anemia. She was diagnosed with AUB and treated with blood transfusions. Abnormal uterine bleeding is defined as bleeding outside normal volume, duration, or frequency. It can be caused by various structural, hematological, endocrine or other issues. Dysfunctional uterine bleeding is defined as abnormal bleeding without an organic cause, and can be ovulatory or anovulatory. Initial management of AUB involves determining the cause and treating any underlying issues medically or surgically.
Functional ovarian cyst and its differential diagnosis Cheng Ting
Functional ovarian cysts are non-cancerous cysts that form due to a temporary hormonal imbalance. They are usually unilateral, asymptomatic, and less than 8 cm in diameter. Functional cysts contain clear fluid and will typically resolve on their own once the hormonal imbalance is addressed. Differential diagnoses for ovarian cysts include ectopic pregnancy, ovarian tumors, and other gastrointestinal or genitourinary conditions. Distinguishing features between functional and cancerous cysts include cyst size, consistency, location, presence of ascites, and diagnostic imaging results.
Adenomyosis is a benign condition where endometrial tissue grows into the myometrium. It causes the uterus to enlarge asymmetrically, especially on the posterior wall. Women with adenomyosis typically experience heavy menstrual bleeding and painful periods that can occur throughout the month. Ultrasound and MRI can detect adenomyosis by showing cysts in the thickened myometrium and an indistinct endomyometrial junction. Treatment depends on a woman's age and fertility desires, ranging from medication like NSAIDs and oral contraceptives to hysterectomy for older, parous women.
Uterine prolapse was first documented in ancient Egypt. The first successful vaginal hysterectomy to treat uterine prolapse was self-performed in 1670. Pelvic organ prolapse has a lifetime risk of around 11% requiring surgery. The uterus is normally supported by the endopelvic fascia, ligaments, and pelvic floor muscles. Prolapse can involve the bladder, uterus, rectum, or vagina descending from their normal positions. Conservative treatment includes pessaries while surgical repair is also used to manage uterine prolapse.
This document discusses fibroids, which are benign growths in the uterus. It notes that fibroids are very common, affecting up to 40% of women, and are more common and symptomatic in black women. While the exact causes are unknown, fibroids develop from the muscle cells of the uterus. The symptoms depend on the location, number, and size of fibroids. Treatment options include medication to manage symptoms, uterine artery embolization to reduce fibroids, and surgical options like myomectomy and hysteroscopic myomectomy to remove fibroids.
Women with benign heavy menstrual bleeding have the choice of a number of medical treatment options to reduce their blood loss and improve quality of life.
This document discusses endometritis, including acute, chronic, and atrophic types. Acute endometritis usually occurs after abortion or childbirth and is caused by various bacteria. Chronic endometritis results from a persistent infection in the uterine cavity caused by things like IUDs or retained products. Atrophic endometritis occurs in postmenopausal women due to loss of estrogen protection. Clinical features include vaginal discharge and abdominal or pelvic pain. Diagnosis involves tests like cervical smears, ultrasounds, and endometrial biopsies. Treatment involves removing the infection source and using antibiotics.
Hematocolpos is a blood-filled dilated vagina caused by menstrual blood buildup due to an anatomical obstruction. It can occur due to conditions like an imperforate hymen or transverse vaginal septum, which is a rare congenital vertical fusion defect that can be either perforate or imperforate and occurs most often in the superior vagina. Patients may experience amenorrhea or abdominal pain, and physical examination can help identify the cause.
This document discusses induction of labor, including its definition, indications, contraindications, methods, and risks. It defines induction of labor as planned initiation of uterine contractions before spontaneous onset. Common indications include prolonged pregnancy and fetal growth restriction. Contraindications include placenta previa and severe fetal compromise. Methods discussed include membrane stripping, amniotomy, prostaglandins like misoprostol and dinoprostone, and oxytocin. Risks of induction include greater pain, uterine hyperstimulation, cord prolapse, and potential need for C-section if induction fails. The document provides three scenarios involving induction and asks for opinions on indications and complications.
Genital tuberculosis is a major health problem in developing countries. It spreads hematogenously from a primary pulmonary infection to the fallopian tubes. Clinical features include infertility, chronic pelvic pain, and menstrual abnormalities. Diagnosis involves blood tests, imaging, endometrial biopsy, and laparoscopy. Treatment consists of a multi-drug chemotherapy regimen for 9-12 months. Prognosis is good for cure but fertility is often not restored due to tubal damage. Surgery may be needed for complications like pyosalpinx but does not improve fertility.
A medical abortion, also known as medication abortion, is a type of non-surgical abortion in which medication is used to bring about abortion. This inflammation is shared with the client in our Clinic.
A Bartholin's cyst is a fluid-filled sac within the Bartholin's gland of the vagina. Bartholin's cysts typically occur in nulliparous women of child-bearing age and other risk factors include a personal history of Bartholin's cyst, being sexually active, or a history of vulval surgery. Bartholin's cysts can cause vulvar pain, dyspareunia, and may rupture spontaneously, relieving pain. Treatment options include incision and drainage with placement of a Word catheter or marsupialization to prevent reaccumulation of fluid.
Bacterial infections during childbirth can lead to sepsis, a life-threatening condition caused by the body's response to an infection. Sepsis is a global leading cause of maternal mortality, accounting for 1 in 10 maternal deaths worldwide. The diagnostic criteria for sepsis include symptoms like fever, increased heart rate, respiratory rate and blood markers of infection. Early goal-directed treatment within 3-6 hours including antibiotics, fluid resuscitation and source control can improve outcomes. Ongoing monitoring and organ support is often needed. Risk factors like obesity, diabetes and preterm rupture of membranes increase the risk of sepsis in pregnancy.
Dysfunctional uterine bleeding (DUB) is a common cause of abnormal uterine bleeding outside of pregnancy, and is caused by functional abnormalities of the hypothalamic-pituitary axis. DUB accounts for the large majority of abnormal uterine bleeding cases. Evaluation involves obtaining a detailed history, physical exam, and endometrial sampling. Treatment options include medical management with various hormonal regimens or surgical options like endometrial ablation or hysterectomy.
F.I.G.O. GUIDELINES & MEDICAL MANAGEMENT OF A.U.B. ( FOCUS ON PROGESTERONE ) ...DR SHASHWAT JANI
This document provides guidelines for evaluating and managing abnormal uterine bleeding (AUB). It discusses the FIGO classification system for AUB which categorizes causes as structural (polyps, adenomyosis, leiomyomas, malignancy) or non-structural (coagulopathy, ovulatory dysfunction, endometrial). Evaluation involves history, physical exam, labs including pregnancy test and CBC, and imaging like ultrasound and hysteroscopy. Treatment focuses on treating the underlying cause, with hormonal therapy commonly used for non-structural causes.
This document discusses fibroids in pregnancy. It notes that fibroids are benign muscle tumors that are quite common, affecting around 1 in 1000 pregnancies. While fibroids often cause no issues, they can sometimes lead to complications for the pregnancy like abortion, preterm labor, malpresentation, or obstructed labor. The effects of pregnancy on fibroids are also covered, as fibroids often enlarge during pregnancy due to increased blood flow and hormones. The diagnosis, management, and treatment of fibroids during pregnancy and delivery are discussed. In general, vaginal delivery is preferred when possible and surgery is avoided during pregnancy.
Seminar presentation by student under supervision of endocrinology specialist from HRPZ. References as mentioned in the slides. Mostly from Malaysia CPG.
uterinefibroid gynaecology easy base of understandingschhataria
1. Uterine fibroids are benign tumors that develop in the muscular wall of the uterus and can cause heavy bleeding, pain, and infertility.
2. Treatment depends on the size, location, and symptoms of the fibroids and the patient's desire for future fertility. Asymptomatic small fibroids may require no treatment, while larger or symptomatic fibroids are often treated with medication, myomectomy (surgical removal of fibroids), or hysterectomy (removal of the uterus).
3. Surgical removal of fibroids (myomectomy) aims to preserve fertility and is recommended for women wishing to maintain their uterus and fertility or for fibroids distorting the uterine cavity.
The document discusses the internal anatomy of the uterus, defining fibroids as benign tumors arising from the smooth muscles of the uterus. It notes that fibroids are most common in women over 30 and in African/Caribbean women. Symptoms include abnormal uterine bleeding, pain, and pressure effects. Ultrasound is the primary investigation. Treatment options include conservative management, medical therapy using GnRH analogues, and surgical options of myomectomy or hysterectomy depending on factors like age and desire for future fertility. Complications include degeneration, sarcomatous change, infection, and torsion. Differential diagnosis includes other pelvic masses and causes of bleeding. Pregnancy can affect fibroids and fibroids can impact pregnancy
This document discusses benign lesions of the uterus, including fibroid uterus, uterine polyps, and endometrial hyperplasia. Fibroid uterus are common benign tumors composed of smooth muscle and fibrous tissue that can cause symptoms like abnormal bleeding, pain, and infertility. Uterine polyps are growths attached by a stalk that can also cause bleeding. Endometrial hyperplasia is excessive growth of the endometrial lining. The document provides details on the causes, symptoms, diagnosis, and treatment of these common benign uterine conditions.
Benign growths in the uterus that can develop during a woman's childbearing years.Highest incidence was seen in Pakistani women 78%, then rural Indian women 37.65%, urban India 24% and Nigerian women 30%. Arobosoba from Nigeria has reported prevalence of uterine fibroids in black women was more (26%), in comparison to Caucasian women (17.9%).
The document discusses benign lesions of the uterus and endometrium. It covers several topics including uterine polyps, endometrial polyps, and fibroids. Uterine polyps can be single or multiple, pedunculated or sessile. Endometrial polyps are common benign growths that present with abnormal bleeding and are detected by ultrasound or hysteroscopy. Fibroids are the most common benign tumors of the uterus, composed of smooth muscle cells, and can cause heavy bleeding or pain.
Fibroid uterus in detail ..... odstetrics and gynecolgyVishnu Ambareesh
Fibroids are benign tumors that occur in the uterus and are quite common, affecting approximately 25% of women. They develop from muscle cells in the uterus and can vary in size and location. The most common symptoms are abnormal uterine bleeding and pain. Clinical examination often reveals an enlarged, irregular uterus, and imaging tests may be used to further evaluate the size and location of any fibroids present. While usually asymptomatic, fibroids can sometimes cause complications during pregnancy like miscarriage or preterm labor, especially if they are located inside the uterine cavity.
Uterine Fibroids (Leiomyomata): Investigations and Treatment Michelle Fynes
Uterine fibroids (UF) are the most common benign neoplastic threat to women's health, costing hundreds of billions of health care dollars worldwide. The objective of this presentation is to review risk factors, aetiology, classification and clinical presentation of Uterine fibroids.
Pelvic inflammatory disease (PID) is an inflammatory condition of the pelvic cavity that is usually caused by bacteria, viruses, or other microbes. It commonly affects sexually active young women and can cause long-term complications like infertility or ectopic pregnancy if left untreated. Symptoms include lower abdominal pain and vaginal discharge. Treatment involves antibiotics, bed rest, and care of any sexual partners. Nursing care focuses on monitoring, education, and supporting patients through treatment.
This document defines uterine fibroids as benign tumors of smooth muscle origin that develop in the uterus. Fibroids are most common in women ages 35-45 and regress after menopause. While the exact causes are unknown, factors like genetics, hormones, and growth factors may contribute to their development. Fibroids can vary in size and location within the uterus. Common symptoms include abnormal uterine bleeding, pain, and infertility. Diagnosis involves physical examination and ultrasound imaging. Potential complications relate to bleeding, pregnancy outcomes, and pressure on surrounding organs. Treatment options range from conservative approaches like hormonal therapy to surgical procedures like hysterectomy or myomectomy depending on factors like symptoms and desire for future fertility.
Benign disease of the uterus includes fibroids, adenomyosis, and uterine polyps. Endometrial polyps are common growths in the uterus that can cause abnormal bleeding. They are more frequently seen in women taking medications like tamoxifen. Uterine fibroids are also very common non-cancerous growths that arise from the muscle cells of the uterus and can cause heavy bleeding and pain. While many fibroids cause no issues, some may lead to complications like infertility or problems in pregnancy. Diagnosis is often done with ultrasound or MRI. Treatment depends on symptoms but may include medication, surgery, or watchful waiting.
gynaecology.Benign tumor of the uterus.(dr.sundus)student
Benign disease of the uterus includes fibroids, adenomyosis, and uterine polyps. Fibroids are non-cancerous tumors that form in the uterus and are very common. They can cause heavy bleeding and pain. Uterine polyps are overgrowths of tissue in the uterus that can also cause abnormal bleeding. While many women do not experience symptoms, fibroids and polyps sometimes require treatment such as surgery to remove them.
- Fibroids are benign smooth muscle tumors that arise from the uterus. They are very common, affecting 20-30% of women.
- Symptoms include heavy menstrual bleeding, pelvic pressure, pain, and infertility. Fibroids can range in size from small to very large masses.
- Diagnosis is usually made through ultrasound imaging. Surgical treatment options include myomectomy to remove fibroids or hysterectomy for multiple or large fibroids. Conservative management is also an option for small asymptomatic fibroids.
Endometriosis is a medical condition where endometrial tissue grows outside the uterus, commonly in the ovaries, fallopian tubes, and pelvic lining. It affects 6-10% of women and causes pain, irregular bleeding, and infertility. The exact cause is unknown but theories include retrograde menstruation, genetic factors, and environmental toxins. Diagnosis involves a medical history, physical exam, ultrasound, MRI, and laparoscopy to visualize lesions. Stages range from minimal to severe based on location, size, and depth of implants. Treatment focuses on pain management and hormone therapy to suppress menstruation. Differential diagnoses include pelvic inflammatory disease, ovarian cysts, and uterine fibroids.
Uterine fibroids, or leiomyomas, are benign tumors that arise from the smooth muscle cells of the uterus. They are the most common solid pelvic tumors in women. While many fibroids do not cause symptoms, they can cause heavy bleeding, pelvic pain or pressure, and problems during pregnancy. Fibroids are diagnosed using ultrasound or other imaging tests and the treatment depends on the severity of symptoms, but may include medication, surgery, or observation.
This document provides information on benign and malignant breast tumors. It begins by discussing the normal anatomy of the breast and then describes several common benign tumors - fibroadenoma, phyllodes tumor, and intraductal papilloma. Fibroadenoma is the most common benign breast tumor and typically appears as a solitary nodule. Phyllodes tumor is rarer and can be large with leaf-like projections. Intraductal papilloma presents with nipple discharge. The document then discusses carcinoma, or malignant breast tumors. Risk factors and pathogenesis of breast cancer are outlined. Carcinomas are classified as non-invasive (in situ) or invasive. Examples of specific tumor types are described along with their
The document discusses several uterine disorders including endometrial polyps, uterine fibroids, endometriosis, and adenomyosis. It provides details on their characteristics, risk factors, clinical presentation, investigations, and treatment options. The document also discusses malignant disorders of the uterus including endometrial cancer and cervical cancer. It covers their etiology, staging, signs and symptoms, diagnostic workup, and management approaches.
Power point presentation of benign lesions of breastmadhurakilledar
This document provides a classification and overview of benign breast diseases and lesions. It discusses developmental abnormalities, inflammatory lesions, epithelial and stromal proliferations, and neoplasms. Specific conditions mentioned include cysts, sclerosing adenosis, fibroadenoma, phyllodes tumor, hamartoma, ductal ectasia, intraductal papilloma, lipoma, focal fibrosis, diabetic mastopathy, pseudoangiomatous stromal hyperplasia, myofibroblastoma, hemangioma, mastitis, tuberculosis, foreign body granuloma, ectopic breast tissue, macromastia, ductal ectasia, ductal hyperplasia, intraductal papillo
This document discusses non-neoplastic disorders of the endometrium. It describes acute and chronic endometritis, adenomyosis, and endometriosis. For adenomyosis, it notes that it refers to growth of endometrial tissue into the myometrium, which can cause menorrhagia and pelvic pain. For endometriosis, it discusses the three theories of histogenesis and lists common locations including the ovaries. It also summarizes abnormal uterine bleeding and its causes including dysfunctional uterine bleeding from anovulation or an inadequate luteal phase.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...rightmanforbloodline
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
2. MEANING:
Fibroids are the tumours composed
of smooth muscle and fibrous
connective tissue of uterus. These
are commonly benign tumours.
- D C. Dutta
4. TUMOURS OF THE BODY OF
UTERUS
I. BENIGN :
1. Adenoma
2. Myoma
II. MALIGNANT :
1. Carcinoma
2. Sarcoma
3. Chorio-
carcinoma
4. Mesodermal
mixed tumour
5. Secondaries
5. INCIDENCE:
20% of women at 30 years of age (asymptomatic)
3% of women in OPD (symptomatic)
10% more prevalence in England
Higher rate in black race
More common in nulliparous or in women having
infertility after 1 child
Highest prevalence between 35-45years
7. HISTOGENESIS :
Risk factors for fibroids:
Increased risk Reduced risk
Nulliparity
Obesity
Hyperestrogenic
state
Black women
Age between 35-45
F/h/o tumour
Multiparity
Smoking
8. ETIOLOGY :
1. Unknown
2. Immature muscle cells present in
myometrium
3. Excessive Oestrogens
- myomas grow during child
bearing age only.
- after menopause the growth of
tumour stops or regression in size
9. Causes of Neoplastic
transformation :
ORIGIN:
1. Chromosomal abnormality:
- About 30% the chromosome abnormality is seen in 6th or 7th
chromosome( rearrangement or deletion)
2. Role of polypeptide growth factors:
- Epidermal growth factors (EGF), Insulin like growth factor-1( IGF-1),
Transforming growth factor (TGF), stimulate the growth of leiomyoma
directly or via estrogen
10. GROWTH:
Predominantly estrogen-dependent tumuor.Oestrogen dependency evidenced by:
Growth potentiality is limited to during child bearing period
Increased growth during pregnancy
They don’t occur before menarche
Following menopause, decrease in size of tumour or cessation of growth.
Frequent association of anovulation
More of oestrogen receptors than adjacent myometrium
11. Contd…
Growth rate is slow & takes about 3-5 years to be felt
per abdomen
Grows rapidly during pregnancy or pill users
Rapid growth can be due to degeneration or malignant
change
12. FEATURES OF TUMOURS:
Arise from muscles not from fibres
Single or multiple ( upto 200)
Size variable from millimeters to the size of foot ball (filling whole
abdomen)
Spherical in shape & firm consistency
Surrounded by pseudo-capsule
Cut surface of the tumour becomes convex & has white whorled appearance
Nuclei rod shaped, uniform in size & shape
13. TYPES OF FIBROIDS:
I. Body (Corporeal)
II. Cervical
1. Interstitial or Intramural
2. Sub-peritoneal or subserous
3. Submucous
4. Pseudo-cervical fibroids
16. INTERSTITIAL or INTRAMURAL:
- In this case the myomas grow & stay in the wall of the
uterus
- Surrounded by myometrial tissue
- Initially fibroids are intramural subsequently pushed
outward or inward
- 70% persist in position.
17. SUBSEROUS:
- Fibroid are partitially or completely covered by
peritoneum
- When completely covered it attains a pedicle called as
‘Pedunculated subserous fibroid’
- If the pedicle is torn then it gets nourishment from
omental or mesenteric adhesions called as ‘Wandering’
or ‘Parasitic fibroid’.
18. Contd…
- If the fibroid is pushed out in between the layers of broad
ligament, called as ‘ Broad ligament fibroid’ ( false or
pseudo)
19. SUBMUCOUS:
- Fibroids grow towards the uterine cavity or cervical canal, may form a polyp
in the cavity & covered by the endometrium.
- They come out through the cervix, may be infected or ulcerated causing
metrorrhagia.
FATE –
Surface necrosis
Polypoid change
Infection
Degerations
21. CERVICAL
o Rare about 1-2%
o Seen in supravaginal part of cervix, may be any one
above type
o May be anterior, posterior, lateral or central depending
on position
o Disturb the pelvic anatomy, specially ureter
25. 1.DEGENERATION:
a. Hyaline degeneration- common type, firm feel of tumour becomes soft
elastic.
b. Cystic degeneration- after the menopause, in interstitial fibroids.
Liquefaction of areas with hyaline changes, if becomes big may be
confused with ovarian cyst or pregnancy
c. Fatty degeneration- at or after menopause, fat globules get deposited in
muscle cells
26. d. Red (carneous) degeneration- occur in 2nd half of
pregnancy or puerperium. Cut section revealing raw
beef appearance, cystic space & fishy odor
e. Calcareous degeneration- common in subserous type
followed by fatty degeneration. There is precipitation
of calcium carbonate or phosphate then whole
tumour is converted into calcified mass called ‘Womb
stone’
27. 2. ATROPHY
Following menopause due to loss of oestrogen support
Reduction in size of tumour ( as similar to that occurs
after pregnancy)
3.NECROSIS :
Inadequacy of circulation leads to central necrosis of
tumour ( in submucous polyp or subserous)
28. 4. INFECTION:
Gains way to tumour through the thinned & sloughed surface epithelium of
submucous fibroid, following abortion or delivery
5. VASCULAR CHANGES:
Dilatation of the vessels (telangiectasis)
Dilatation of lymphatic channels occur.
6. SARCOMATOUS CHANGES:
Occur in less than 0.1%
Usual type is lieomyosarcoma.
29. CHANGES IN THE PELVIC
ORGANS:
> Uterus- Shape distorted, asymmetrical
-Endometrium with features of anovulation with hyperplasia, as result
becomes thick, congested & edematous
> Uterine tubes- Frequent infection
> Ovaries- Enlarged, congested & filled
with multiple cysts.
> Ureter- Compressed leading to
hydroureter or hydronephrosis
30. CLINICAL FEATURES:
PATIENT PROFILE:
Usually nalliparous
Chronic secondary infertility
Early marriage
Frequent child birth
Age between 35-45 years
Delayed menopause
31. Contd…
SYMPTOMS:
Asymptomatic (75%)
Symptoms depend on anatomic type & size
Symptoms depend on the site than the size
Small submucous fibroid may produce more symptoms than big subserous
fibroid
32. I. Menstrual abnormalities:
1. Menorrhagia (30%)
CAUSES:
Increased surface area of endometrium
Interference with normal contractility
Congestion & dilatation venous plexuses
Endometrial hyperplasia due to hyperoestrinism
Pelvic congestion
Role of prostanoids
34. Contd…
3. Dysmenorrhoea:
Congestive variety- may be associated with pelvic congestion or
endometriosis
Spasmodic type- may be associated with extrusion of polyp & its
expulsion from the uterine cavity
35. Contd… II. INFERTILITY:
CAUSES:
1. Uterine –
> Distortion & or elongation of uterine cavity difficult sperm ascent
Prevent rhythmic uterine contraction during intercourse impaired
sperm transport
Congestion & dilatation of endometrial venous plexuses defctive
nidation
Atrophy & ulceration of endometrium
36. Contd…
2. Tubal –
Conual block due position of fibroid
Marked elongation of tubes over big fibroid
Association salpingitis with tubal block
3. Ovarian – Anovulation
4. Peritoneal – Endometriosis
5. Unknown
37. III. Pregnancy related
problems:
Abortion
Preterm labour
IUGR
PPH
Causes:
- Defective implantation of placenta
- Poorly developed endometrium
- Reduced space for the growing fetus
38. IV. Pain lower abdomen
Usually painless
CAUSES:
- Due to tumour degeneration
- Torsion subserous pedunculated fibroid
- Extrusion of polyp
- Associated pathology like PID, endometriosis
39. V. Abdominal swelling
- Heaviness in lower abdomen
VI. Pressure symptoms:
- Constipation
- Dysuria
- Retention of urine
- Hydroureter
- Hydronephrosis
- Infection
- Pyelitis
40. SIGNS:
1. Pallor
2. Enlargement of abdomen
3. Firm feel on palpation
4. Restricted mobility
5. Dullness on percussion
6. bimanul findings
- Irregular uterus
- Cervix moves with movement of tumour
45. COMPLICATIONS:
Persistent menorrhagia, metrorrhagia or vaginal
bleeding leading to severe anaemia
Severe intraperitoneal haemorrhage
Severe infection leading to peritonitis or septicaemia
Sarcoma
46. ASYMPTOMATIC FIBROID:
1. Observation:
Perform diagnostic tests
Begin expectant therapy
Size < 12 wks of pregnancy
Diagnosis certain
Follow up
Periodic examination at 6mth interval
Observe the symptoms of fibroids
47. Contd…
2. Surgery:
Indications:
- Size >12 wks of pregnancy
- Diagnosis not certain
- Fibroid grows during follow up
- Subserous pedunculated fibroid
- Unexplained infertility with distortion of uterine cavity
- Unexpalined recurrent abortion
- Present in lower pole of uterus likely to complicate delivery
50. Contd…
4. Central cervical:
- Produce bladder symptoms
- Cervix expanded on all sides
- Asymptomatic during pregnancy
- Obstruction during labour.
- If pedunculated, sensation of something coming out, if infected a foul
smelling discharge per vagina
51. TREATMENT:
1. Supravaginal fibroids:
Myomectomy – Its not only technically difficult but the anatomic &
functional restoration of cervix cannot be adequate to achieve the
future reproduction
Hysterectomy
2. Vaginal part fibroids:
Myomectomy
If, pedunculated polypectomy
52. PREGNANCY AND MYOMAS
EFFECTS OF MYOMAS ON PREGNANCY:
1. During pregnancy
Abortion: distortion pf uterine cavity, defective implantation,
interference with accomodation & increase in size, impaction of
myoma in pelvis
Premature onset of labour
Malpresentation
53. contd…
2. During labour:
Abnormal uterine action
Cervical dystcia
Obstructed labour
Retainned placenta
Post partum haemorrhage
3. During puerperium:
Puerperal sepsis
Delayed involution of uterus
54. Contd…
EFFECTS OF PREGNANCY ON MYOMAS:
Increase in size
Change in consistency
Red degeneration
Torsion & infection